Impedimed (Australia) Price History

IPD Stock   0.05  0  1.92%   
Below is the normalized historical share price chart for Impedimed extending back to October 24, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Impedimed stands at 0.05, as last reported on the 27th of November, with the highest price reaching 0.05 and the lowest price hitting 0.05 during the day.
IPO Date
24th of October 2007
200 Day MA
0.0705
50 Day MA
0.0568
Beta
2.874
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Impedimed Stock, it is important to understand the factors that can impact its price. Currently, Impedimed is out of control. Impedimed holds Efficiency (Sharpe) Ratio of 0.035, which attests that the entity had a 0.035% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Impedimed, which you can use to evaluate the volatility of the firm. Please check out Impedimed's Risk Adjusted Performance of 0.0154, market risk adjusted performance of 0.0536, and Downside Deviation of 4.23 to validate if the risk estimate we provide is consistent with the expected return of 0.16%.
  
At this time, Impedimed's Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 12 M in 2024, whereas Common Stock is likely to drop slightly above 185.5 M in 2024. . Impedimed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.035

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsIPD
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.56
  actual daily
40
60% of assets are more volatile

Expected Return

 0.16
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
2
98% of assets perform better
Based on monthly moving average Impedimed is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Impedimed by adding it to a well-diversified portfolio.
Price Book
2.5827
Enterprise Value Ebitda
(9.34)
Price Sales
10.0011
Shares Float
1.8 B
Wall Street Target Price
0.1457

Impedimed Stock Price History Chart

There are several ways to analyze Impedimed Stock price data. The simplest method is using a basic Impedimed candlestick price chart, which shows Impedimed price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 18, 20240.067
Lowest PriceSeptember 10, 20240.044

Impedimed November 27, 2024 Stock Price Synopsis

Various analyses of Impedimed's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Impedimed Stock. It can be used to describe the percentage change in the price of Impedimed from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Impedimed Stock.
Impedimed Accumulation Distribution 71,848 
Impedimed Price Daily Balance Of Power(0.25)
Impedimed Price Rate Of Daily Change 0.98 

Impedimed November 27, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Impedimed Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Impedimed intraday prices and daily technical indicators to check the level of noise trading in Impedimed Stock and then apply it to test your longer-term investment strategies against Impedimed.

Impedimed Stock Price History Data

The price series of Impedimed for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 0.02 with a coefficient of variation of 9.19. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.05. The median price for the last 90 days is 0.06. The company completed 368:355 stock split on 3rd of April 2020.
OpenHighLowCloseVolume
11/27/2024 0.05  0.05  0.05  0.05  934,030 
11/26/2024 0.05  0.05  0.05  0.05  1,467,505 
11/25/2024 0.06  0.06  0.05  0.05  1,115,272 
11/22/2024 0.05  0.06  0.05  0.06  2,263,828 
11/21/2024 0.05  0.06  0.05  0.05  2,011,259 
11/20/2024 0.05  0.05  0.05  0.05  1,180,129 
11/19/2024 0.05  0.06  0.05  0.05  837,482 
11/18/2024 0.05  0.06  0.05  0.05  2,291,840 
11/15/2024 0.05  0.05  0.05  0.05  1,292,107 
11/14/2024 0.05  0.05  0.05  0.05  120,151 
11/13/2024 0.06  0.06  0.05  0.05  105,998 
11/12/2024 0.06  0.06  0.05  0.06  805,016 
11/11/2024 0.06  0.06  0.06  0.06  1,124,281 
11/08/2024 0.06  0.06  0.06  0.06  1,141,606 
11/07/2024 0.05  0.06  0.05  0.06  623,923 
11/06/2024 0.05  0.05  0.05  0.05  697,048 
11/05/2024 0.05  0.05  0.05  0.05  218,310 
11/04/2024 0.05  0.05  0.05  0.05  326,440 
11/01/2024 0.05  0.06  0.05  0.06  587,107 
10/31/2024 0.06  0.06  0.05  0.06  405,182 
10/30/2024 0.06  0.06  0.05  0.05  1,079,304 
10/29/2024 0.06  0.06  0.05  0.06  2,047,848 
10/28/2024 0.06  0.06  0.05  0.06  1,413,571 
10/25/2024 0.06  0.06  0.05  0.06  795,978 
10/24/2024 0.06  0.06  0.05  0.06  1,790,183 
10/23/2024 0.06  0.06  0.06  0.06  1,487,637 
10/22/2024 0.06  0.07  0.06  0.06  4,900,704 
10/21/2024 0.07  0.07  0.06  0.06  1,635,327 
10/18/2024 0.07  0.07  0.07  0.07  941,019 
10/17/2024 0.07  0.07  0.07  0.07  426,392 
10/16/2024 0.06  0.07  0.06  0.07  1,782,321 
10/15/2024 0.07  0.07  0.06  0.06  1,362,216 
10/14/2024 0.06  0.07  0.06  0.07  2,388,014 
10/11/2024 0.06  0.06  0.06  0.06  262,932 
10/10/2024 0.06  0.06  0.06  0.06  314,564 
10/09/2024 0.06  0.06  0.06  0.06  313,512 
10/08/2024 0.06  0.06  0.06  0.06  2,587,724 
10/07/2024 0.06  0.06  0.06  0.06  297,979 
10/04/2024 0.06  0.06  0.06  0.06  820,743 
10/03/2024 0.06  0.06  0.06  0.06  833,425 
10/02/2024 0.06  0.06  0.06  0.06  1,375,806 
10/01/2024 0.06  0.06  0.06  0.06  843,396 
09/30/2024 0.06  0.06  0.06  0.06  448,756 
09/27/2024 0.06  0.06  0.06  0.06  428,743 
09/26/2024 0.06  0.06  0.05  0.06  2,686,033 
09/25/2024 0.06  0.06  0.05  0.06  1,044,202 
09/24/2024 0.06  0.07  0.05  0.06  5,027,981 
09/23/2024 0.06  0.06  0.06  0.06  3,672,687 
09/20/2024 0.05  0.06  0.05  0.05  3,783,470 
09/19/2024 0.05  0.05  0.05  0.05  996,185 
09/18/2024 0.05  0.05  0.05  0.05  1,685,278 
09/17/2024 0.05  0.05  0.05  0.05  455,114 
09/16/2024 0.05  0.05  0.05  0.05  450,385 
09/13/2024 0.05  0.05  0.05  0.05  1,855,943 
09/12/2024 0.04  0.05  0.04  0.05  4,892,824 
09/11/2024 0.04  0.04  0.04  0.04  7,306,742 
09/10/2024 0.05  0.05  0.04  0.04  6,265,281 
09/09/2024 0.05  0.05  0.04  0.05  258,968 
09/06/2024 0.05  0.05  0.05  0.05  1,564,009 
09/05/2024 0.05  0.05  0.04  0.05  5,021,068 
09/04/2024 0.05  0.05  0.05  0.05  4,044,228 

About Impedimed Stock history

Impedimed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Impedimed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Impedimed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Impedimed stock prices may prove useful in developing a viable investing in Impedimed
Last ReportedProjected for Next Year
Common Stock Shares OutstandingB2.1 B
Net Loss-18.5 M-19.4 M

Impedimed Quarterly Net Working Capital

24.8 Million

Impedimed Stock Technical Analysis

Impedimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Impedimed technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Impedimed trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Impedimed Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Impedimed's price direction in advance. Along with the technical and fundamental analysis of Impedimed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Impedimed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.